ロード中...
Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantation
The optimal management of patients with diffuse large B cell lymphoma relapsing after autologous haematopoetic stem cell transplantation (HCT) is difficult and no standard treatment has been defined. The authors here report the case of a rituximab-naive patient who relapsed after HCT and was cured w...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3391410/ https://ncbi.nlm.nih.gov/pubmed/22761205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.02.2012.5856 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|